Previous 10 | Next 10 |
2023-08-06 08:01:00 ET The second week of August promises to be an eventful one for investors as a slew of major companies is set to report quarterly results. Among the headliners, Disney ( NYSE: DIS ) is prehaps the most well-known company due to report. The schedule also incl...
SOUTH SAN FRANCISCO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
23andMe is the first and only direct-to-consumer product to offer a suite of FDA-authorized pharmacogenetics reports, with medication insights Lipid-lowering statins are one of the most commonly prescribed medications in the United States, and genetics can play a major role on the body&...
Toronto, Ontario--(Newsfile Corp. - July 5, 2023) - Moneta Gold Inc. (TSX: ME) (OTCQX: MEAUF) (FSE: MOPA) ("Moneta" or the "Company") is proud to release its inaugural Environmental, Social, and Governance ("ESG") Report for the 2022 reporting period, highlighting the achievements and efforts...
SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today released a new report as part of the 23andMe+ subscription service on the genetics of panic attacks, or episodes of intense anxi...
Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - Moneta Gold Inc. (TSX: ME) (OTCQX: MEAUF) (FSE: MOPA) ("Moneta" or the "Company") is pleased to announce assay results from fifty-four (54) resource infill and step-out drill holes on the Westaway deposit at the Tower Gold project (the "Pro...
2023-06-17 07:00:25 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genes are the foundation of human life. They are the code that gives every instruction to our bodies about how to move, digest and think. So understanding those genes can be critical to underst...
2023-06-15 01:44:28 ET Summary 23andMe entered its IPO with two down years on revenue but has since reclaimed low double-digit growth. Throughout this time, however, the company has not made identifiable progress toward profitability on either an accrual or cash basis. It continue...
2023-06-09 18:26:17 ET 23andMe ( NASDAQ: ME ) said in an SEC filing that it plans to lay off about 9% of its workforce, or around 75 employees, as part of a company restructuring. The genetics-focused healthcare company said it expects the cuts to be made mostly during Q1 o...
Toronto, Ontario--(Newsfile Corp. - June 2, 2023) - Moneta Gold Inc. (TSX: ME) (OTCQX: MEAUF) (FSE: MOPA) ("Moneta" or the "Corporation") announced the approval of each of the matters set out in the Corporation's Management Information Circular (the " Circular ") dated April 18, 2023 at the 2...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading genetic health and biopharmaceutical company, in collaboration with 20 lung cancer advocacy organizations, today announced a new study to help advance research in lung cancer. The focus of the Lun...